Company Filing History:
Years Active: 2018
Title: Yannis Sainte-Marie: Innovator in Biomarkers of Mineralocorticoid Receptor Activation
Introduction
Yannis Sainte-Marie is a notable inventor based in Toulouse, France. He has made significant contributions to the field of medical research, particularly in the area of biomarkers related to mineralocorticoid receptor activation. His work has implications for predicting patient responses to specific treatments.
Latest Patents
Yannis Sainte-Marie holds a patent for "Biomarkers of mineralocorticoid receptor activation." This invention relates to the use of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and/or SERPINA3 as biomarkers for mineralocorticoid receptor activation in patients. The method described in the patent involves determining the expression levels of the NGAL gene and/or the SERPINA3 gene in biological samples to predict a patient's responsiveness to treatments with MR antagonists or aldosterone synthase inhibitors. He has 1 patent to his name.
Career Highlights
Yannis Sainte-Marie is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work is recognized for its potential to enhance treatment strategies for patients with conditions related to mineralocorticoid receptor activation.
Collaborations
Yannis has collaborated with esteemed colleagues, including Frederic Jaisser and Nicolette Farman, to advance research in this critical area of medical science.
Conclusion
Yannis Sainte-Marie's innovative work in identifying biomarkers for mineralocorticoid receptor activation represents a significant advancement in medical research. His contributions have the potential to improve patient care and treatment outcomes.